Abstract | BACKGROUND AND OBJECTIVES: METHODS: 574 patients who underwent hepatectomy by 17 surgeons (Open 536 and Laparoscopic 38) for HCC without major vascular invasion from 1990 to 2013 at single institute were retrospectively analyzed. RESULTS: Huge tumor, age, HCV, multiple tumors and microscopic portal invasion are independent risk factors for overall survival (OS), and huge tumor, ICGR15 ≥16%, multiple tumors, moderate/poor histology, microscopic portal invasion and a positive pathological margin are risk factors for relapse-free survival (RFS). The 5-year OS and RFS of patients with huge HCC (n = 53) (42.9 and 14.2%) were significantly worse than those of patients with HCC <10 cm (n = 521) (71.3 and 33.1%). Huge tumor is an independent risk factor for initial extra-hepatic recurrence (Hazard ratio 7.86, P < 0.0001). The 5-year OS of patients with initial extra-hepatic recurrence (n = 55) was significantly worse than patients with intra-hepatic recurrence (n = 338) (16.8 vs. 50.5%). CONCLUSIONS: Huge HCC (≥10 cm) is an independent risk factor due to a high risk for initial extra-hepatic recurrence. Future systemic adjuvant therapy is needed for these patients. J. Surg. Oncol. 2017;115:324-329. © 2016 Wiley Periodicals, Inc.
|
Authors | Kenji Wakayama, Toshiya Kamiyama, Hideki Yokoo, Tatsuya Orimo, Shingo Shimada, Takahiro Einama, Hirofumi Kamachi, Akinobu Taketomi |
Journal | Journal of surgical oncology
(J Surg Oncol)
Vol. 115
Issue 3
Pg. 324-329
(Mar 2017)
ISSN: 1096-9098 [Electronic] United States |
PMID | 28192617
(Publication Type: Journal Article)
|
Copyright | © 2016 Wiley Periodicals, Inc. |
Topics |
- Carcinoma, Hepatocellular
(blood supply, pathology, surgery)
- Cohort Studies
- Female
- Hepatectomy
- Humans
- Liver Neoplasms
(blood supply, pathology, surgery)
- Male
- Middle Aged
- Neoplasm Recurrence, Local
(pathology)
- Neoplasm Staging
- Prognosis
- Retrospective Studies
- Survival Rate
- Treatment Outcome
|